ziprasidone sandoz
sandoz s.p.a. - ziprasidone - ziprasidone
ziprasidone mylan generics
mylan s.p.a. - ziprasidone - ziprasidone
ziprasidone teva
teva italia s.r.l. - ziprasidone - ziprasidone
zeldox
viatris pharma s.r.l. - ziprasidone - ziprasidone
zeldox
pricetag spa - ziprasidone - ziprasidone
zeldox
general pharma solutions spa - ziprasidone - ziprasidone
xtandi
astellas pharma europe b.v. - enzalutamide - neoplasie prostatiche - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
ivabradina aurobindo
aurobindo pharma (italia) s.r.l. - ivabradina - ivabradina
serenase
istituto luso farmaco d'italia s.p.a. - aloperidolo - aloperidolo
mantadan
hikma farmaceutica (portugal) s.a. - amantadina - amantadina